Form 4: Elevance Health HR Chief Acquires Stock & Options

Elevance Health's EVP & Chief HR Officer, Ryan R. Craig, acquired 970 restricted stock units and 3,690 employee stock options on September 2, 2025.

Summary

• Ryan R. Craig, Executive Vice President & Chief HR Officer of Elevance Health, Inc. (ELV), acquired 970 shares of common stock in the form of restricted share units (RSUs) on September 2, 2025.
• These restricted share units will vest in three tranches: 323 shares on September 2, 2026, 323 shares on September 2, 2027, and 324 shares on September 2, 2028.
• Additionally, Mr. Craig was granted employee stock options to purchase 3,690 shares of common stock on September 2, 2025, with an exercise price of $322.33 per share.
• The stock options become exercisable in three annual installments of 1,230 shares, beginning on September 2, 2026, which marks the one-year anniversary of the grant date.
• The employee stock options are set to expire on September 2, 2035.
• Following these transactions, Mr. Craig beneficially owns 5,353 shares of common stock and 3,690 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: The filing reflects a positive alignment of executive and shareholder interests through equity compensation, which is a standard and generally well-regarded practice. It does not contain any negative news or unexpected events.

Positives

• The acquisition of restricted stock units and stock options aligns the interests of the EVP & Chief HR Officer with those of the company's shareholders.
• Executive compensation in the form of equity grants is a standard practice that incentivizes long-term performance and retention of key management personnel.

Future Outlook

The filing details future vesting schedules for restricted stock units and exercisability dates for stock options, indicating a long-term incentive structure for the executive.

Industry Context

Executive equity compensation, including restricted stock units and stock options, is a common practice across the healthcare and broader corporate sectors to attract, retain, and motivate senior leadership by linking their financial success to the company's performance.

Comparison to Industry Standards

• The structure of equity grants, involving both restricted stock units and stock options with multi-year vesting schedules, is consistent with typical executive compensation packages observed in large-cap healthcare companies like UnitedHealth Group (UNH) or Cigna Group (CI).
• The exercise price of $322.33 for the options reflects the market price at the time of grant, a standard practice for at-the-money options, similar to grants at peer companies.

Stakeholder Impact

• Shareholders: The equity grants align the executive's financial incentives with long-term shareholder value creation, potentially leading to more focused management decisions.
• Employees: Standard executive compensation practices can signal stability and a structured approach to talent management within the company.

Next Steps

• The restricted stock units will vest in tranches on September 2, 2026, September 2, 2027, and September 2, 2028.
• The employee stock options will become exercisable in three annual installments, starting September 2, 2026.

Key Dates

Recommendation

The filing details routine executive compensation in the form of restricted stock units and stock options, which aligns the EVP & Chief HR Officer's interests with shareholders. This is a standard practice and does not provide new fundamental information to change an investment thesis, hence a 'hold' recommendation is appropriate. Investors should consider broader company performance and market conditions for investment decisions.

Keywords

Elevance Health, ELV, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Stock Options, Ryan R. Craig